A Semmelweis Egyetemen kezelt Ewing-szarkómás gyermekek kezelési eredményeinek vizsgálata

Zsófia Geiszl, János Kiss, M. Szendrői, Júlia Vízkeleti, Gabriella Arató, Z. Sápi, Gergely Kriván, Anna Mohás, Imre Rényi, M. Garami, P. Hauser

Research output: Article

Abstract

The survival of children treated with Ewing sarcoma at Semmelweis University were investigated. Pediatric patients with Ewing sarcoma treated at Semmelweis University from 2001 through 2013 were analyzed in terms of overall survival and clinical factors (age, primary localization and extent of the tumor, time interval from primary complaints to diagnosis). For statistical analysis Kaplan-Meier estimated survival and log rank test were applied. Mean age and follow-up time of the 78 patients were 11.16 and 6.29 years, respectively. In 57% of patients time interval from primary symptoms to diagnosis was less than half year. In 53.8% of the patients the disease was metastatic at primary diagnosis (pulmonary only: 29.5%, any other: 24.3%). 5- and 10-year overall survival of patients were 68.1% and 60.4%, respectively. Among the analyzed factors, the presence of metastasis impaired 5-year overall survival significantly (88.5% for localized disease, 63.5% for pulmonary only and 40.9% for any other metastasis). The survival rate of pediatric patients with Ewing sarcoma treated at Semmelweis University is similar to the result in Western European countries.

Original languageHungarian
Pages (from-to)230-236
Number of pages7
JournalMagyar Onkologia
Volume62
Issue number4
Publication statusPublished - dec. 12 2018

Fingerprint

Ewing's Sarcoma
Pediatrics
Survival
Neoplasm Metastasis
Age Factors
Kaplan-Meier Estimate
Lung Diseases
Survival Rate
Lung
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

A Semmelweis Egyetemen kezelt Ewing-szarkómás gyermekek kezelési eredményeinek vizsgálata. / Geiszl, Zsófia; Kiss, János; Szendrői, M.; Vízkeleti, Júlia; Arató, Gabriella; Sápi, Z.; Kriván, Gergely; Mohás, Anna; Rényi, Imre; Garami, M.; Hauser, P.

In: Magyar Onkologia, Vol. 62, No. 4, 12.12.2018, p. 230-236.

Research output: Article

Geiszl, Z, Kiss, J, Szendrői, M, Vízkeleti, J, Arató, G, Sápi, Z, Kriván, G, Mohás, A, Rényi, I, Garami, M & Hauser, P 2018, 'A Semmelweis Egyetemen kezelt Ewing-szarkómás gyermekek kezelési eredményeinek vizsgálata', Magyar Onkologia, vol. 62, no. 4, pp. 230-236.
Geiszl, Zsófia ; Kiss, János ; Szendrői, M. ; Vízkeleti, Júlia ; Arató, Gabriella ; Sápi, Z. ; Kriván, Gergely ; Mohás, Anna ; Rényi, Imre ; Garami, M. ; Hauser, P. / A Semmelweis Egyetemen kezelt Ewing-szarkómás gyermekek kezelési eredményeinek vizsgálata. In: Magyar Onkologia. 2018 ; Vol. 62, No. 4. pp. 230-236.
@article{4ddad6b1d39f414b948ef4d071387d16,
title = "A Semmelweis Egyetemen kezelt Ewing-szark{\'o}m{\'a}s gyermekek kezel{\'e}si eredm{\'e}nyeinek vizsg{\'a}lata",
abstract = "The survival of children treated with Ewing sarcoma at Semmelweis University were investigated. Pediatric patients with Ewing sarcoma treated at Semmelweis University from 2001 through 2013 were analyzed in terms of overall survival and clinical factors (age, primary localization and extent of the tumor, time interval from primary complaints to diagnosis). For statistical analysis Kaplan-Meier estimated survival and log rank test were applied. Mean age and follow-up time of the 78 patients were 11.16 and 6.29 years, respectively. In 57{\%} of patients time interval from primary symptoms to diagnosis was less than half year. In 53.8{\%} of the patients the disease was metastatic at primary diagnosis (pulmonary only: 29.5{\%}, any other: 24.3{\%}). 5- and 10-year overall survival of patients were 68.1{\%} and 60.4{\%}, respectively. Among the analyzed factors, the presence of metastasis impaired 5-year overall survival significantly (88.5{\%} for localized disease, 63.5{\%} for pulmonary only and 40.9{\%} for any other metastasis). The survival rate of pediatric patients with Ewing sarcoma treated at Semmelweis University is similar to the result in Western European countries.",
author = "Zs{\'o}fia Geiszl and J{\'a}nos Kiss and M. Szendrői and J{\'u}lia V{\'i}zkeleti and Gabriella Arat{\'o} and Z. S{\'a}pi and Gergely Kriv{\'a}n and Anna Moh{\'a}s and Imre R{\'e}nyi and M. Garami and P. Hauser",
year = "2018",
month = "12",
day = "12",
language = "Hungarian",
volume = "62",
pages = "230--236",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "4",

}

TY - JOUR

T1 - A Semmelweis Egyetemen kezelt Ewing-szarkómás gyermekek kezelési eredményeinek vizsgálata

AU - Geiszl, Zsófia

AU - Kiss, János

AU - Szendrői, M.

AU - Vízkeleti, Júlia

AU - Arató, Gabriella

AU - Sápi, Z.

AU - Kriván, Gergely

AU - Mohás, Anna

AU - Rényi, Imre

AU - Garami, M.

AU - Hauser, P.

PY - 2018/12/12

Y1 - 2018/12/12

N2 - The survival of children treated with Ewing sarcoma at Semmelweis University were investigated. Pediatric patients with Ewing sarcoma treated at Semmelweis University from 2001 through 2013 were analyzed in terms of overall survival and clinical factors (age, primary localization and extent of the tumor, time interval from primary complaints to diagnosis). For statistical analysis Kaplan-Meier estimated survival and log rank test were applied. Mean age and follow-up time of the 78 patients were 11.16 and 6.29 years, respectively. In 57% of patients time interval from primary symptoms to diagnosis was less than half year. In 53.8% of the patients the disease was metastatic at primary diagnosis (pulmonary only: 29.5%, any other: 24.3%). 5- and 10-year overall survival of patients were 68.1% and 60.4%, respectively. Among the analyzed factors, the presence of metastasis impaired 5-year overall survival significantly (88.5% for localized disease, 63.5% for pulmonary only and 40.9% for any other metastasis). The survival rate of pediatric patients with Ewing sarcoma treated at Semmelweis University is similar to the result in Western European countries.

AB - The survival of children treated with Ewing sarcoma at Semmelweis University were investigated. Pediatric patients with Ewing sarcoma treated at Semmelweis University from 2001 through 2013 were analyzed in terms of overall survival and clinical factors (age, primary localization and extent of the tumor, time interval from primary complaints to diagnosis). For statistical analysis Kaplan-Meier estimated survival and log rank test were applied. Mean age and follow-up time of the 78 patients were 11.16 and 6.29 years, respectively. In 57% of patients time interval from primary symptoms to diagnosis was less than half year. In 53.8% of the patients the disease was metastatic at primary diagnosis (pulmonary only: 29.5%, any other: 24.3%). 5- and 10-year overall survival of patients were 68.1% and 60.4%, respectively. Among the analyzed factors, the presence of metastasis impaired 5-year overall survival significantly (88.5% for localized disease, 63.5% for pulmonary only and 40.9% for any other metastasis). The survival rate of pediatric patients with Ewing sarcoma treated at Semmelweis University is similar to the result in Western European countries.

UR - http://www.scopus.com/inward/record.url?scp=85058607440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058607440&partnerID=8YFLogxK

M3 - Article

C2 - 30540865

AN - SCOPUS:85058607440

VL - 62

SP - 230

EP - 236

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 4

ER -